Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In people without diabetes, Wegovy has a low intrinsic risk of hypoglycaemia, though reduced appetite may lead to inadvertent meal skipping in susceptible individuals
Hansen, L
Regulatory Context for GLP-1 Telehealth Programs in 2026 The telehealth GLP-1 industry has been under increased regulatory scrutiny throughout early 2026
Phase 3 TRIUMPH trials have shown average weight loss of up to 28.7%, the highest ever recorded in an obesity drug trial
US$ 24.20
US$ 21.58
US$ 24.52
US$ 23.96
US$ 25.44
US$ 23.24
US$ 29.41
US$ 25.84
